⌘K

Login Start Free

Home/Filings/4/0000899243-19-009064

4//SEC Filing

La Barge Joseph 4

Accession 0000899243-19-009064

CIK 0001609351other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 7:20 PM ET

Size

25.3 KB

Accession

0000899243-19-009064

Insider Transaction Report

Form 4

Period: 2019-03-25

Spark Therapeutics, Inc.ONCE

La Barge Joseph

See remarks

Transactions

Exercise/Conversion
Common Stock
2019-03-25$56.17/sh+12,500$702,125→ 56,836 total
Exercise/Conversion
Stock Option (right to buy)
2019-03-25−7,000→ 21,000 total
Exercise: $50.55Exp: 2028-01-17→ Common Stock (7,000 underlying)
Exercise/Conversion
Common Stock
2019-03-25$68.45/sh+41,755$2,858,130→ 63,237 total
Tax Payment
Common Stock
2019-03-25$113.38/sh−21,260$2,410,459→ 44,336 total
Exercise/Conversion
Common Stock
2019-03-25$50.55/sh+7,000$353,850→ 54,963 total
Tax Payment
Common Stock
2019-03-25$113.42/sh−31,389$3,560,140→ 31,848 total
Tax Payment
Common Stock
2019-03-25$113.36/sh−4,770$540,727→ 50,193 total
Exercise/Conversion
Stock Option (right to buy)
2019-03-25−12,500→ 12,500 total
Exercise: $56.17Exp: 2027-01-17→ Common Stock (12,500 underlying)
Exercise/Conversion
Common Stock
2019-03-25$40.44/sh+33,748$1,364,769→ 65,596 total
Tax Payment
Common Stock
2019-03-25$113.36/sh−8,873$1,005,843→ 47,963 total
Exercise/Conversion
Stock Option (right to buy)
2019-03-25−41,755→ 0 total
Exercise: $68.45Exp: 2025-03-15→ Common Stock (41,755 underlying)
Exercise/Conversion
Stock Option (right to buy)
2019-03-25−33,748→ 11,250 total
Exercise: $40.44Exp: 2026-01-04→ Common Stock (33,748 underlying)

Holdings

Common Stock
(indirect: Held by Reporting Person's immediate family members)
200

Footnotes (4)

[F1]25% vested March 16, 2016 and the remainder vested in equal quarterly installments over the following three years.
[F2]25% vested January 5, 2017 and the remainder vests in equal quarterly installments over the following three years.
[F3]25% vested January 18, 2018 and the remainder vests in equal annual installments over the following three years.
[F4]25% vested January 18, 2019 and the remainder vests in equal annual installments over the following three years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeother

Related Parties

1

filerCIK 0001673526

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 7:20 PM ET
Size: 25.3 KB

View on SEC.gov